Prentice Wealth Management LLC Lipocine Inc. Transaction History

Prentice Wealth Management LLC

  • $329 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022
SELL
$0.73 - $1.34 $182 - $335
-250 Closed
0 $0
Q1 2021

Jun 17, 2021
SELL
$1.38 - $2.28 $176 - $291
-128 Reduced 33.86%
250 $1,000
Q1 2021

Jun 08, 2021
BUY
$1.38 - $2.28 $521 - $861
378 New
378 $1,000

About Lipocine Inc.

LPCN Quotes by TradingView
  • Ticker LPCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,510,800
  • Market Cap $418M
  • Description
  • Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...
More about LPCN
Track This Portfolio

Track Prentice Wealth Management LLC Portfolio

Follow Prentice Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prentice Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email